Thymus-independent and thymus-dependent responses to polysaccharide antigens

KE Stein - Journal of Infectious Diseases, 1992 - academic.oup.com
Immune responses to polysaccharide antigens are thymus-independent (TI). Conversion of
a polysaccharide antigen to a thymus-dependent (TD) antigen by covalent coupling to an …

Immunology of bacterial polysaccharide antigens

A Weintraub - Carbohydrate research, 2003 - Elsevier
Carbohydrates in the form of capsular polysaccharides and/or lipopolysaccharides are the
major components on the surface of bacteria. These molecules are important virulence …

[HTML][HTML] Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells

B Shi, L Sepp-Lorenzino, M Prisco, P Linsley… - Journal of Biological …, 2007 - ASBMB
The insulin receptor substrate-1 (IRS-1), a docking protein for both the type 1 insulin-like
growth factor receptor (IGF-IR) and the insulin receptor, is known to send a mitogenic, anti …

Monophosphoryl lipid A as an adjuvant: past experiences and new directions

JT Ulrich, KR Myers - Vaccine design: the subunit and adjuvant approach, 1995 - Springer
The increasing threat to the human population posed by new or resurgent infectious
diseases, coupled with an alarming rise in the incidence of antibiotic-resistant microbes, has …

Capsular polysaccharides as human vaccines

HJ Jennings - Advances in Carbohydrate Chemistry and Biochemistry, 1983 - Elsevier
Publisher Summary This chapter discusses the use of capsular polysaccharides as human
vaccines. Vaccination has proved to be one of the most useful scientific developments in the …

Neonatal administration of idiotype or antiidiotype primes for protection against Escherichia coli K13 infection in mice.

KE Stein, T Söderström - The Journal of experimental medicine, 1984 - rupress.org
Antibodies directed against the capsular polysaccharides (Ps) of encapsulated pathogenic
bacteria can protect the host against infection with such organisms. The immune response to …

Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future

JB Robbins - Immunochemistry, 1978 - Elsevier
It is an honor for me and my colleagues to participate in this colloquium acknowledging the
scientific accomplishments and the special contribution of Professor Michael Heideiberger to …

A distinct role for B1b lymphocytes in T cell-independent immunity

KR Alugupalli - … and Complementation of Humoral Immune Responses …, 2008 - Springer
Pathogenesis of infectious disease is not only determined by the virulence of the microbe
but also by the immune status of the host. Vaccination is the most effective means to control …

Enhancement of the neonate's nonspecific immunity to Klebsiella infection by muramyl dipeptide, a synthetic immunoadjuvant.

M Parant, F Parant, L Chedid - Proceedings of the National …, 1978 - National Acad Sciences
N-acetylmuramyl-L-alanyl-D-isoglutamine (muramyl dipeptide) and certain derivatives that
are structural analogs of part of the bacterial peptidoglycan monomer have been shown to …

Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.

MI Marks, EJ Ziegler, H Douglas… - The Journal of …, 1982 - Am Soc Clin Investig
Efforts to prevent Haemophilus influenzae type b (HIB) infections in infancy have been
hampered by the low immunogenicity of capsular polysaccharide vaccines in children …